Home > Inhibitors & Agonists > Cell Cycle/DNA Damage > Monopolar Spindle 1 (Mps1/TTK)

Monopolar Spindle 1 (Mps1/TTK)

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC11704 CFI-401870 A potent, selective, orally active Mps1 (TTK) inhibitor with IC50 of 3.1 nM.
DC11677 CCT-271850 A potent, selective, orally bioavailable Mps1 kinase inhibitor with IC50 of 11 nM.
DC7072 AZ3146 Featured AZ3146 is a potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM); less potent to FAK, JNK1, JNK2, and Kit.
DC9679 BAY1217389 Featured BAY1217389 is an orally bioavailable, selective inhibitor of the serine/threonine kinase monopolar spindle 1 (Mps1, TTK), with potential antineoplastic activity.
DC7470 MPI-0479605 Featured MPI-0479605 is an ATP competitive and selective inhibitor of mitotic kinase Mps1 with IC50 of 1.8 nM, >40-fold selectivity over other kinases.
DC8119 Mps1-IN-2 Featured Mps1-IN-2 is a potent Mps1 kianse inhibitor with IC50 value of 145 nM.
DC5087 Mps1-IN-1 Mps1-IN-1 is a highly potent and selectibe Mpsl inhibitor with IC50 of 367 nM; >1000-fold selectivity relative to the 352 member kinase panel with the major exceptions of Alk and Ltk.
DC7866 NMS-P715 Featured NMS-P715 is the first selective, ATP-competitive and orally bioavailable MPS1 small-molecule inhibitor(IC50=8 nM); selectively reduces cancer cell proliferation, leaving normal cells almost unaffected.
DC28264 TC-Mps1-12 TC-Mps1-12 is a potent and selective monopolar spindle 1 (Mps1) inhibitor, with an IC50 of 6.4 nM.
DC70063 CFI-402257(luvixasertib) Featured CFI-402257(luvixasertib) is a potent and selective Mps1/TTK kinase inhibitor with Ki of 0.1 nM and cellular Mps1 EC50 of 6.5 nM.
DC73202 SYL1073 SYL1073 is a potent, selective and covalent Threonine tyrosine kinase (TTK) inhibitor with IC50 of of 16 nM.
<PrevNext >

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>